Clinical Trials Directory

Trials / Completed

CompletedNCT02968875

Alzheimer's Disease and Physiological, Cognitive Function and BDNF Levels of Plasma Adaptation After Exercise Training

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
54 (actual)
Sponsor
University Hospital Center of Martinique · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Alzheimer's disease (AD) is a neurodegenerative disease leading to one of the most common forms of dementia in humans and memory disorder is one of the first symptoms that lead to diagnosis.

Detailed description

Present in greater amounts in the regions of the hippocampus and cortex, the Brain-derived neurotrophic factor (BDNF) is essential to both learning and memory processes. This protein is found in lower amounts in people with AD. Acute physical activity of moderate to vigorous intensity would increase the levels of plasma BDNF whether for a healthy person or a person with AD. Nevertheless in rest, healthy people have higher level of BDNF than individuals with AD. There are no studies on the effect of chronic exercise based on BDNF level at rest in people with AD. In a hypothetical endurance training of 18 sessions, whether interval or continuous training the levels of BDNF would increase in people with AD at rest. Their physiological and neuropsychological performances would also show a rise.

Conditions

Interventions

TypeNameDescription
DEVICEEndurance Training40 people will submitted to endurance training: 20 will perform a continuous training and 20 will perform an interval training. The variables that will be analyzed are maximum aerobic power, endurance, heart rate, prehension strength, Mini-Mental State Examination (MMSE), REY's test, biological examination and level of BDNF plasma, before and after the intervention and one month after the end of the intervention and one month after the end of the intervention.
OTHERtherapeutic education meetingsGroup of 20 people will be the control group and will not perform ET. However, they will have 9 therapeutic education meetings.

Timeline

Start date
2015-07-01
Primary completion
2017-12-01
Completion
2018-02-01
First posted
2016-11-21
Last updated
2018-05-29

Locations

1 site across 1 country: Martinique

Source: ClinicalTrials.gov record NCT02968875. Inclusion in this directory is not an endorsement.